Arcellx (ACLX)

• Market cap: $4.24B
• 1 day: 0.34%
• 5 days: -20.02%
• 1 month: -15.51%
• 3 months: 4.79%
• 6 months: 18.24%
• Year to date: -6.98%
• 1 year: -19.47%
• 5 years: 336.01%
• 10 years: 336.01%
• Sector: Healthcare
• Industry: Biotechnology

About: Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Employees: 163